Evidence map›Paper›PMID 39710996›Full record

ArticleBrain and behavior2024

Causal Relationship Between the Abuse of Cholesterol-Lowering Medication, Blood Pressure Medication, Insulin, and Exogenous Hormones and Cerebral Infarction.

Jing Liu, Dongsheng Lv, Shiduo Li, Zhansen An, Zefeng He, Yingzi Liu

Abstract read
In one paragraph

Article in Brain and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jing LiuDepartment of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Dongsheng LvDepartment of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Shiduo LiDepartment of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Zhansen AnDepartment of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Zefeng HeDepartment of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Yingzi LiuDepartment of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCholesterol-lowering medications, blood pressure medication, insulin, and exogenous hormones (including hormone replacement therapy, oral contraceptives, and minipills) are commonly utilized in clinical practice. Recent studies indicate that the use of these medications may significantly influence the occurrence and progression of cerebral infarction. This study aims to investigate the relationship between these medications and cerebral infarction using Mendelian randomization (MR) analysis, with the goal of offering valuable insights for the clinical management of cerebral infarction.

methodsTo explore the correlation between cholesterol-lowering medication, blood pressure medication, insulin, exogenous hormones, and cerebral infarction, relevant single nucleotide polymorphisms (SNPs) were extracted from the genome-wide association study (GWAS) database. Methods for univariate MR analysis include inverse variance weighting (IVW), the weighted median method, and the MR-Egger method, with IVW being the predominant approach. Subsequently, multivariable Mendelian randomization (MVMR) was conducted on the positive results obtained from the IVW analysis to verify the independent effect of each positive exposure, with IVW still predominating. The causal relationship between this class of drugs and cerebral infarction was evaluated using odds ratio (OR) and 95% confidence interval (CI). MR-PRESSO was used to test for pleiotropy. The robustness of the findings was assessed through leave-one-out analysis, Cochran's Q test, and funnel plot.

resultsUnivariate MR results indicated that the use of blood pressure medication, insulin, and cholesterol-lowering medication was significantly associated with the occurrence of cerebral infarction (all p < 0.05). However, due to the stringent inclusion criteria for SNPs, the number of available SNPs is insufficient to elucidate the association between exogenous hormone drugs, contraceptives, and cerebral infarction. Furthermore, the MVMR analysis, which builds upon univariate MR, only identified significant causal associations between blood pressure medication, insulin, and cerebral infarction (p < 0.05). The association between cholesterol-lowering medication and cerebral infarction was confounded by other positive exposures and did not demonstrate a significant causal relationship when only its independent effects were considered. After integrating the findings from both univariate and MVMR and controlling for confounding variables to the greatest extent possible, the available evidence supports only a potential causal relationship between blood pressure medication, insulin, and cerebral infarction.

conclusionThis study suggests that the misuse of blood pressure medications and insulin is a risk factor for the occurrence and progression of cerebral infarction.

Indexed as

Antihypertensive AgentsCerebral InfarctionInsulinMendelian Randomization AnalysisPolymorphism, Single NucleotideAnticholesteremic AgentsGenome-Wide Association StudyHormone Replacement TherapyHumansAnticholesteremic AgentsAntihypertensive AgentsInsulinblood pressure medicationcausal associationcerebral infarctioninsulinMendelian randomization

Identifiers

PMID39710996
PMCPMC11663836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.